Austin Private Wealth LLC grew its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 12.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,368 shares of the company’s stock after acquiring an additional 801 shares during the period. Austin Private Wealth LLC’s holdings in Procter & Gamble were worth $1,235,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of PG. Concurrent Investment Advisors LLC increased its position in Procter & Gamble by 4.5% during the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after buying an additional 4,035 shares during the last quarter. Copley Financial Group Inc. bought a new position in shares of Procter & Gamble during the 3rd quarter worth approximately $668,000. Fortem Financial Group LLC acquired a new position in shares of Procter & Gamble during the 4th quarter worth approximately $569,000. Nordea Investment Management AB raised its stake in Procter & Gamble by 7.5% in the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock valued at $484,583,000 after acquiring an additional 201,695 shares during the period. Finally, Synovus Financial Corp lifted its holdings in Procter & Gamble by 3.4% during the 3rd quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock valued at $32,065,000 after purchasing an additional 6,077 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, insider Marc S. Pritchard sold 90,450 shares of the business’s stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the sale, the insider now owns 172,814 shares of the company’s stock, valued at $28,313,845.76. The trade was a 34.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 151,097 shares of company stock worth $25,635,076. Insiders own 0.18% of the company’s stock.
Procter & Gamble Trading Down 0.9 %
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. The firm had revenue of $21.88 billion during the quarter, compared to the consensus estimate of $21.66 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.84 earnings per share. Equities analysts anticipate that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be issued a dividend of $1.0065 per share. The ex-dividend date is Friday, January 24th. This represents a $4.03 annualized dividend and a dividend yield of 2.43%. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.01%.
Wall Street Analyst Weigh In
PG has been the topic of several research analyst reports. JPMorgan Chase & Co. dropped their price objective on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. DA Davidson restated a “buy” rating and set a $209.00 price objective on shares of Procter & Gamble in a research report on Thursday, January 23rd. Wells Fargo & Company upped their target price on Procter & Gamble from $176.00 to $180.00 and gave the company an “overweight” rating in a research report on Thursday, January 23rd. Evercore ISI boosted their price target on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Finally, UBS Group decreased their price objective on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. Eight equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $180.53.
Check Out Our Latest Research Report on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- 3 Healthcare Dividend Stocks to Buy
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Why Invest in High-Yield Dividend Stocks?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- What is a Death Cross in Stocks?
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.